These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17184969)

  • 1. The effectiveness of Teratology Information Services (TIS).
    Hancock RL; Koren G; Einarson A; Ungar WJ
    Reprod Toxicol; 2007 Feb; 23(2):125-32. PubMed ID: 17184969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Providing information regarding exposures in pregnancy: a survey of North American Teratology Information Services.
    Hancock RL; Ungar WJ; Einarson A; Goodstadt M; Koren G
    Reprod Toxicol; 2008 Apr; 25(3):381-7. PubMed ID: 18423962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge transfer and translation: examining how teratogen information is disseminated.
    Shahin I; Einarson A
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):956-61. PubMed ID: 21948595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services.
    Schaefer C
    Congenit Anom (Kyoto); 2011 Mar; 51(1):6-11. PubMed ID: 21158950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection bias in Teratology Information Service pregnancy outcome studies.
    Johnson KA; Weber PA; Jones KL; Chambers CD
    Teratology; 2001 Aug; 64(2):79-82. PubMed ID: 11460258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
    Schaefer C; Hannemann D; Meister R
    Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paternal exposure and counselling: experience of a Teratology Information Service.
    De Santis M; Cesari E; Cavaliere A; Ligato MS; Nobili E; Visconti D; Caruso A
    Reprod Toxicol; 2008 Sep; 26(1):42-6. PubMed ID: 18598753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who seeks Teratology Information Service's advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy.
    Beck E; Lechner A; Schaefer C
    Reprod Toxicol; 2017 Jan; 67():79-84. PubMed ID: 27915015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience of two teratology information services in Europe.
    Garbis JM; Robert E; Peters PW
    Teratology; 1990 Dec; 42(6):629-34. PubMed ID: 2087683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International practices in the provision of teratology information: a survey of international teratogen information programmes and comparisons with the North American model.
    Hancock RL; Ungar WJ; Einarson A; Koren G
    J Eval Clin Pract; 2010 Oct; 16(5):957-63. PubMed ID: 20590976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.
    Schaefer C; Ornoy A; Clementi M; Meister R; Weber-Schoendorfer C
    Reprod Toxicol; 2008 Sep; 26(1):36-41. PubMed ID: 18588969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmarketing surveillance for drug safety in pregnancy: the Organization of Teratology Information Services project.
    Felix RJ; Jones KL; Johnson KA; McCloskey CA; Chambers CD;
    Birth Defects Res A Clin Mol Teratol; 2004 Dec; 70(12):944-7. PubMed ID: 15570610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing concerns of pregnant and lactating women after the 2005 hurricanes: the OTIS response.
    Quinn D; Lavigne SV; Chambers C; Wolfe L; Chipman H; Cragan JD; Rasmussen SA
    MCN Am J Matern Child Nurs; 2008; 33(4):235-41. PubMed ID: 18664905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
    Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
    Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratological risk evaluation and prevention of voluntary abortion.
    De Santis M; Straface G; Cavaliere AF; Cinque B; Carducci B; Caruso A
    Minerva Ginecol; 2006 Apr; 58(2):91-9. PubMed ID: 16582865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of paternal drug exposure: the Motherisk experience.
    Lee CY; Jin C; Mata AM; Tanaka T; Einarson A; Koren G
    Reprod Toxicol; 2010 Jun; 29(3):353-60. PubMed ID: 20096774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal occupational exposure to solvents and congenital malformations: a prospective study in the general population.
    Garlantézec R; Monfort C; Rouget F; Cordier S
    Occup Environ Med; 2009 Jul; 66(7):456-63. PubMed ID: 19541806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical approval for multicenter cohort studies on drug exposure during pregnancy: A survey among members of the European Network of Teratology Information Services (ENTIS).
    Winterfeld U; Weber-Schöndorfer C; Schaefer C; von Elm E; Buclin T
    Reprod Toxicol; 2018 Sep; 80():68-72. PubMed ID: 29913205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Funding for teratology information services: up, down, and all around.
    Quinn D
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):660-3. PubMed ID: 22678653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.